[HIF prolyl hydroxylase inhibitors and malignancy: tumor-promoting risks and tumor-suppressive effects mediated by tumor-associated macrophages].

Tomita S, Matsunaga S

Open source

DOI
10.1254/fpj.26070
Published
2026
Container
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1254/fpj.26070,
  title = {[HIF prolyl hydroxylase inhibitors and malignancy: tumor-promoting risks and tumor-suppressive effects mediated by tumor-associated macrophages].},
  author = {Tomita S and Matsunaga S},
  year = {2026},
  journal = {Nihon yakurigaku zasshi. Folia pharmacologica Japonica},
  doi = {10.1254/fpj.26070},
  url = {https://doi.org/10.1254/fpj.26070}
}

RIS

TY  - JOUR
TI  - [HIF prolyl hydroxylase inhibitors and malignancy: tumor-promoting risks and tumor-suppressive effects mediated by tumor-associated macrophages].
AU  - Tomita S
AU  - Matsunaga S
PY  - 2026
JO  - Nihon yakurigaku zasshi. Folia pharmacologica Japonica
DO  - 10.1254/fpj.26070
UR  - https://doi.org/10.1254/fpj.26070
ER  - 

APA

S, T., & S, M. (2026). [HIF prolyl hydroxylase inhibitors and malignancy: tumor-promoting risks and tumor-suppressive effects mediated by tumor-associated macrophages].. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. https://doi.org/10.1254/fpj.26070

Source records